Digital Twins in Biopharma: Regulatory Considerations
Digital Twins in Biopharma: How AI is Accelerating Drug Innovation In an era of rapid scientific progress, the biopharmaceutical industry is turning to digital twins to break traditional barriers in drug discovery and production. Using virtual replicas of physical assets, processes, or systems, digital twins in biopharma are reshaping how companies accelerate drug innovation, reduce time to...
0 Comments 0 Shares